As of Feb 16
| -0.37 / -0.67%|
The 14 analysts offering 12-month price forecasts for Seattle Genetics Inc have a median target of 66.50, with a high estimate of 75.00 and a low estimate of 47.00. The median estimate represents a +22.06% increase from the last price of 54.48.
The current consensus among 16 polled investment analysts is to Hold stock in Seattle Genetics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.